macro

Cardinal Health beats revenue and profit estimates, raises FY27 earnings outlook

Cardinal Health topped analyst expectations for fiscal first-quarter revenue and adjusted earnings per share, and raised its fiscal 2027 profit guidance.

the same feed is available to bots and dashboards through the api. connect the api →

what happened

US pharmaceutical distributor Cardinal Health reported that fiscal first-quarter revenue rose 5%, ahead of analyst forecasts. Adjusted earnings per share climbed 28%, also above expectations. Reuters attributes the figures to the company and LSEG data.

The company lifted its fiscal 2027 non-GAAP EPS guidance to $12.80–$13.00 from $12.40–$12.60. It now expects profit growth in its Pharmaceutical and Specialty Solutions segment of 10% to 12%, up from 8% to 11%. The non-GAAP effective tax rate outlook was narrowed to 18.5%–19.5% from 19.0%–20.0%.

Segment profit in Pharmaceutical and Specialty Solutions rose 17% during the quarter, mainly on brand and specialty products and a positive generics program. Net income reached $554 million.

why it matters

For the market, this signals resilience in the drug distribution business. Higher revenue and profit, a lower tax rate and a smaller share count all support earnings expectations. According to Reuters, the average analyst rating on the shares is buy, and the median 12-month price target is $280.

market impact

Cardinal Health shares: earnings beat and raised guidance support the stock

  • Cardinal Health shares pressure up — earnings beat and raised guidance support expectations for profit

tags

instruments

Cardinal HealthCAH

sources

  1. Cardinal Health beats Q1 revenue, adjusted EPS estimates, raises outlook — Reuters, 5 November 2026 at 11:53 UTC
  2. Tapestry Q1 revenue and adjusted EPS beat estimates, outlook raised — Reuters, 5 November 2026 at 11:53 UTC
  3. Astrana Health Q3 adjusted EPS beats, revenue meets estimates — Reuters, 5 November 2026 at 21:45 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗